FDA Inspection 1175527 — Seaco National Corp. DBA Southeast Pet
The FDA completed an inspection of Seaco National Corp. DBA Southeast Pet on July 12, 2022 in Austell, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Austell, GA (United States)
Additional Details
FSVP